X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8925) 8925
Publication (974) 974
Book Review (51) 51
Book Chapter (14) 14
Magazine Article (6) 6
Conference Proceeding (3) 3
Dissertation (3) 3
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5580) 5580
animals (4340) 4340
index medicus (3909) 3909
male (3848) 3848
thiazoles - pharmacology (3413) 3413
female (2649) 2649
thiazoles - therapeutic use (2212) 2212
rats (1896) 1896
pharmacology & pharmacy (1587) 1587
mice (1555) 1555
middle aged (1420) 1420
thiazoles (1391) 1391
adult (1316) 1316
thiazoles - administration & dosage (1200) 1200
aged (1034) 1034
thiazolidinediones (1015) 1015
dose-response relationship, drug (1012) 1012
thiazoles - adverse effects (951) 951
thiazoles - chemistry (826) 826
tetrazolium salts (804) 804
thiazoles - pharmacokinetics (797) 797
dasatinib (786) 786
biochemistry & molecular biology (734) 734
hematology (693) 693
time factors (688) 688
oncology (681) 681
neurosciences (676) 676
analysis (674) 674
cells, cultured (614) 614
thiazoles - metabolism (609) 609
treatment outcome (584) 584
cell line, tumor (567) 567
administration, oral (566) 566
rats, sprague-dawley (563) 563
in-vitro (552) 552
expression (531) 531
apoptosis (517) 517
thiazoles - blood (496) 496
article (492) 492
endocrinology & metabolism (489) 489
hypoglycemic agents - therapeutic use (481) 481
chemistry, medicinal (479) 479
cancer (478) 478
cell survival - drug effects (478) 478
research (468) 468
hypoglycemic agents - pharmacology (460) 460
diabetes mellitus, type 2 - drug therapy (450) 450
troglitazone (450) 450
pyrimidines - therapeutic use (432) 432
rats, wistar (408) 408
piperazines - therapeutic use (401) 401
aged, 80 and over (399) 399
cell line (399) 399
imatinib mesylate (399) 399
meloxicam (391) 391
pharmacokinetics (389) 389
disease models, animal (384) 384
drug therapy (379) 379
insulin resistance (375) 375
cells (371) 371
care and treatment (368) 368
structure-activity relationship (368) 368
dogs (367) 367
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (364) 364
double-blind method (363) 363
apoptosis - drug effects (355) 355
cell biology (348) 348
pyrimidines - pharmacology (339) 339
activation (337) 337
adolescent (332) 332
blood glucose - metabolism (331) 331
toxicology (329) 329
mice, inbred c57bl (328) 328
flow cytometry (324) 324
in vitro techniques (324) 324
physiological aspects (322) 322
health aspects (316) 316
inhibition (315) 315
therapy (315) 315
protein kinase inhibitors - therapeutic use (313) 313
antineoplastic agents - pharmacology (308) 308
thiazoles - chemical synthesis (307) 307
blood pressure - drug effects (305) 305
cell proliferation - drug effects (305) 305
metabolism (303) 303
proteins (303) 303
thiazolidines (303) 303
antineoplastic agents - therapeutic use (292) 292
drug therapy, combination (289) 289
oxidative stress (289) 289
brain (288) 288
benzamides (286) 286
clinical neurology (286) 286
benzothiazoles (285) 285
medicine & public health (284) 284
immunology (281) 281
kinetics (279) 279
research article (279) 279
in-vivo (275) 275
young adult (275) 275
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8682) 8682
German (71) 71
Japanese (58) 58
Russian (43) 43
French (32) 32
Chinese (22) 22
Italian (15) 15
Spanish (5) 5
Dutch (3) 3
Polish (3) 3
Czech (2) 2
Danish (2) 2
Korean (2) 2
Ukrainian (2) 2
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 32, pp. 4017 - 4025
Therapeutic drug monitoring (TDM) provides valuable guidance for dose adjustment of antibiotics, immunosuppressives, antiepileptics, and other drugs, but its... 
ANTI-CD20 MONOCLONAL-ANTIBODY | ONCOLOGY | FC-GAMMA-RIIIA | PROGRESSION-FREE SURVIVAL | MULTICENTER PHASE-II | SQUAMOUS-CELL CARCINOMA | TYROSINE KINASE INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | SUNITINIB MALATE SU11248 | CHRONIC MYELOID-LEUKEMIA | IMATINIB PLASMA-LEVELS | Neoplasms - metabolism | Niacinamide - analogs & derivatives | Piperazines - administration & dosage | Thiazoles - blood | Injections, Intravenous | Area Under Curve | Pyrimidines - blood | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Half-Life | Thiazoles - administration & dosage | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Benzenesulfonates - administration & dosage | Drug Monitoring - methods | Indoles - administration & dosage | Antibodies, Monoclonal - blood | Antibodies, Monoclonal, Humanized | Neoplasms - blood | Antineoplastic Agents - adverse effects | Pyrroles - administration & dosage | Benzenesulfonates - blood | Antineoplastic Agents - pharmacokinetics | Cetuximab | Piperazines - blood | Everolimus | Molecular Targeted Therapy - methods | Dasatinib | Sirolimus - analogs & derivatives | Pyridines - administration & dosage | Pyrimidines - administration & dosage | Indoles - blood | Rituximab | Pyrroles - blood | Sirolimus - blood | Evidence-Based Medicine | Imatinib Mesylate | Neoplasms - drug therapy | Sirolimus - administration & dosage | Antibodies, Monoclonal, Murine-Derived - blood | Pyridines - blood | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - blood | Benzamides
Journal Article
Cell, ISSN 0092-8674, 2011, Volume 145, Issue 6, pp. 863 - 874
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 08/2008, Volume 112, Issue 4, pp. 1005 - 1012
Journal Article
FASEB Journal, ISSN 0892-6638, 03/2006, Volume 20, Issue 3, pp. 542 - 544
It is widely believed that the potencies of nonsteroid anti-inflammatory drugs ( NSAIDs) as inhibitors of cyclooxygenase ( COX) are influenced by protein... 
SITE | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | nonsteroid anti-inflammatory drugs | coxibs | PROSTAGLANDIN H-2 SYNTHASE | CELL BIOLOGY | CYCLO-OXYGENASE-2 | THERAPY | FLUID | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | BIOLOGY | prostaglandins | SELECTIVITY | Organic Chemicals - cerebrospinal fluid | Humans | Naproxen - pharmacology | Synovial Fluid - metabolism | Pyrazoles - cerebrospinal fluid | Sodium Salicylate - pharmacology | Lactones - pharmacology | Aspirin - cerebrospinal fluid | Cell Line - drug effects | Calcium - physiology | Pyrazoles - blood | Organic Chemicals - pharmacology | Dinoprostone - cerebrospinal fluid | Diclofenac - cerebrospinal fluid | Aspirin - pharmacology | Sulfones - cerebrospinal fluid | Aspirin - blood | Thiazines - blood | Sulfonamides - pharmacology | Indomethacin - cerebrospinal fluid | Indomethacin - pharmacology | Cyclooxygenase 1 - drug effects | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - blood | Diclofenac - pharmacology | Thiazoles - blood | Thromboxane A2 - blood | Cerebrospinal Fluid Proteins - pharmacology | Dinoprostone - biosynthesis | Lactones - cerebrospinal fluid | Blood Platelets - enzymology | Cyclooxygenase 2 Inhibitors - cerebrospinal fluid | Sodium Salicylate - cerebrospinal fluid | Sulfones - pharmacology | Blood Proteins - pharmacology | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Naproxen - cerebrospinal fluid | Sodium Salicylate - blood | Thiazines - pharmacology | Cyclooxygenase 2 Inhibitors - blood | Cyclooxygenase Inhibitors - cerebrospinal fluid | Blood Platelets - drug effects | Sulfones - blood | Organic Chemicals - blood | Ionophores - pharmacology | Pyrazoles - pharmacology | Sulfonamides - cerebrospinal fluid | Cyclooxygenase 2 Inhibitors - pharmacology | Thiazoles - cerebrospinal fluid | Celecoxib | Diclofenac - blood | Dinoprostone - blood | Naproxen - blood | Organ Specificity | Calcimycin - pharmacology | Cyclooxygenase Inhibitors - pharmacology | Indomethacin - blood | Protein Binding | Thiazines - cerebrospinal fluid | Thiazoles - pharmacology
Journal Article
Circulation, ISSN 0009-7322, 05/2002, Volume 105, Issue 19, pp. 2296 - 2302
Background-Pioglitazone and rosiglitazone, thiazolidinedione peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activators, reduce blood pressure... 
Hypertension | Inflammation | Remodeling | Muscle, smooth | Arteries | MIGRATION | remodeling | THIAZOLIDINEDIONE | CARDIAC & CARDIOVASCULAR SYSTEMS | muscle, smooth | ZUCKER FATTY RATS | arteries | TYPE-1 RECEPTOR | INSULIN | inflammation | GENE-EXPRESSION | PPAR-GAMMA | PERIPHERAL VASCULAR DISEASE | ESSENTIAL-HYPERTENSION | ROSIGLITAZONE | HEMATOLOGY | hypertension | SMOOTH-MUSCLE CELLS | Inflammation - chemically induced | Receptors, Angiotensin - metabolism | Angiotensin II - administration & dosage | Body Weight - drug effects | Endothelium, Vascular - drug effects | Male | Thiazoles - administration & dosage | Inflammation - metabolism | Inflammation - drug therapy | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Injections, Subcutaneous | Lipids - blood | DNA - biosynthesis | Blood Pressure - drug effects | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Drug Administration Schedule | Pioglitazone | Aldosterone - blood | Rats | Cell Cycle Proteins - biosynthesis | Renin - blood | Rats, Sprague-Dawley | Blood Vessels - cytology | Cell Division - drug effects | Transcription Factors - metabolism | Collagen - metabolism | Animals | Endothelium, Vascular - metabolism | NF-kappa B - biosynthesis | Blood Vessels - drug effects | Rosiglitazone | Blood Vessels - physiology | In Vitro Techniques | Vascular Cell Adhesion Molecule-1 - metabolism | Thiazolidinediones | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 12/2014, Volume 53, Issue 12, pp. 2167 - 2174
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal Article
Journal of Cerebral Blood Flow and Metabolism, ISSN 0271-678X, 2017, Volume 37, Issue 2, pp. 740 - 749
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 07/2009, Volume 877, Issue 22, pp. 1982 - 1996
The treatment of some cancer patients has shifted from traditional, non-specific cytotoxic chemotherapy to chronic treatment with molecular targeted therapies.... 
Nilotinib | Dasatinib | Plasma | Imatinib | Sunitinib | Sorafenib | Lapatinib | LC–MS/MS | Anticancer targeted therapy | Tyrosine kinase inhibitors | LC-MS/MS | CHRONIC MYELOGENOUS LEUKEMIA | CHEMISTRY, ANALYTICAL | HUMAN PLASMA | BIOCHEMICAL RESEARCH METHODS | KINASE INHIBITOR | CLINICAL PHARMACOKINETICS | CHRONIC MYELOID-LEUKEMIA | PERFORMANCE LIQUID-CHROMATOGRAPHY | FACTOR RECEPTOR INHIBITOR | IN-VITRO | REFRACTORY SOLID TUMORS | GASTROINTESTINAL STROMAL TUMORS | Niacinamide - analogs & derivatives | Thiazoles - blood | Pyrimidines - blood | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Drug Monitoring - methods | Thiazoles - therapeutic use | Benzenesulfonates - blood | Piperazines - blood | Pyrroles - therapeutic use | Tandem Mass Spectrometry - methods | Pyridines - therapeutic use | Indoles - blood | Piperazines - therapeutic use | Pyrroles - blood | Imatinib Mesylate | Quinazolines - blood | Neoplasms - drug therapy | Pyridines - blood | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Antineoplastic Agents - blood | Indoles - therapeutic use | Benzamides | Chromatography, Liquid - methods | Tyrosine | Chemotherapy | Plasma physics | Formic acid | Nitriles | Rain and rainfall | Health aspects | Phosphotransferases | Mass spectrometry | Cancer | Index Medicus
Journal Article